Teva Pharmaceutical (TEVA) Tops Q1 EPS by 2c
Teva Pharmaceutical (NYSE: TEVA) reported Q1 EPS of $1.12, $0.02 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
